Strength
150 mg/1
Manufacturer
LXO US Inc.NDC
70839015030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2025
Active Ingredients
ALISKIREN HEMIFUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA021985On Market Since
3/5/2007
Pharmacological Classes
Renin Inhibitor
Renin Inhibitors
Related Drugs
Same classification
No related drugs found.